Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of VAX-ID® 2200, a New Device for Intradermal Injections
Sponsor: Memorial Sloan Kettering Cancer Center
Summary
The researchers are doing this study to find out whether the VAX-ID® 2200 device is safe and easy to use for healthcare professionals who give intradermal injections. The VAX-ID® 2200 is a small device that attaches to a standard syringe and guides the needle to the right depth in the skin. This helps make sure the injection is given correctly every time.
Official title: Usability Assessment and Sharps Injury Prevention Testing Protocol for VAX-ID® 2200: A Human Factors Engineering (HFE) Study by Healthcare Professionals
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
15
Start Date
2026-09-11
Completion Date
2027-09-11
Last Updated
2026-10-27
Healthy Volunteers
Yes
Conditions
Interventions
VAX-ID® 2200
This study consists of two independent parts which will be executed consecutively to assess the VAX- ID® 2200 intradermal injection system's (1) usability and (2) sharps injury prevention. The study will involve a cohort of 15 licensed healthcare professionals, composed of 3 doctors, 10 nurses, and 2 pharmacists. Our objective is to establish a cohort of at least 15 participants in total in accordance with FDA recommendation \[3\], fully reflecting the diverse global population \[4\] (including approximately 1-2 left-handed individuals). Of these, a subset of 8 healthcare professionals (1 doctor, 6 nurses, and 1 pharmacist) will execute on the evaluation of the sharps injury prevention feature.
Locations (1)
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States